Health Care Technology
Company Overview of MEDai, Inc.
MEDai, Inc. provides clinical and financial intelligence solutions primarily for payers and provider markets. The company provides Pinpoint Review, which predicts patient needs and provides staff alerts; Pinpoint Quality that monitors outcomes and physician performance to identify opportunities for clinical, financial, and operational improvement; and Pinpoint Compliance, which delivers regulatory reports for performance improvement. It also offers Risk Navigator Clinical, a predictive tool that identifies and manages high-risk populations to improve patient quality; Risk Navigator Guidelines that monitors member and physician compliance with evidence-based guidelines; and Risk Navigator Per...
4901 Vineland Road
Millenia Park One
Orlando, FL 32811
Founded in 1988
Key Executives for MEDai, Inc.
Co-Founder and Executive Vice President
Chief Executive Officer of Elsevier Health Sciences
Compensation as of Fiscal Year 2014.
MEDai, Inc. Key Developments
Caradigm and MEDai Align to Help Healthcare Organizations Manage Risk, Optimize Care and Improve Population Health
Oct 15 13
Caradigm announced it has signed an agreement with MEDai. Under the agreement, Caradigm will enrich its population health solutions with the predictive clinical analytics capabilities of MEDai's solution, enabling customers to stratify patient populations according to severity, disease state, cost or risk profile. This will allow risk-bearing organizations to use their network of resources to focus care on those who will benefit most, helping create a positive impact on overall health outcomes and total cost of care. When coupled with Caradigm(R) Care Management software, providers can develop personalized care plans that specify problems, goals and interventions, and manage patients and conditions through timely interventions enabled by near real-time, event-based alerts.
AmeriBen/IEC Group Chooses Elsevier's MEDai Inc.'s Risk Navigator Clinical(R) Software
Oct 15 12
Elsevier's MEDai, Inc. announced a new licensing agreement with AmeriBen/IEC Group for MEDai's Risk Navigator Clinical(R) software. MEDai's Risk Navigator Clinical will assist AmeriBen, which manages more than 150,000 lives, in its population management. MEDai will provide AmeriBen with Risk Navigator Clinical, a robust solution to analyze and understand their care populations, and execute on strategies to improve the quality of care, reduce costs and waste, and ultimately impact health for their members. Risk Navigator Clinical leverages predictive analytics to transform raw data into intelligent insight that payers can use to allocate resources efficiently and intervene before adverse, costly outcomes occur. Through an easy-to-use web interface, Risk Navigator's results outline areas that provide the potential for intervention and management, allowing stakeholders to improve operations and set competitive premium rates.
Elsevier/MEDai, Inc. Announces Executive Appointments
Aug 20 12
Elsevier/MEDai, Inc. announced the appointment of two key clinicians to its leadership team. Peter Edelstein, M.D., has been appointed Chief Medical Officer, and Gerald Osband, M.D., has been appointed Director, Product Strategy. Dr. Edelstein brings a wealth of knowledge to the organization, including 17 years in the clinical arena and healthcare industry. He then spent more than a decade as an executive in the Silicon Valley medical device industry. Before joining Elsevier/MEDai, Dr. Edelstein most recently served as a physician executive within the Adventist Health System. Dr. Osband is a seasoned clinician and physician executive whose senior level positions include Chief Medical Officer and Chief Operations Officer for nationally recognized healthcare management and technology organizations. He has provided independent consulting services for several major TPAs and a data management and guidelines organization. His clinical experience is the result of 18 years of family medicine practice, including positions teaching family medicine residents and nurse practitioners. Dr. Osband has a broad background and demonstrated leadership in indemnity and managed care programs for group health, workers compensation and disability products inclusive of clinical, operational, quality, and sales responsibilities. His extensive experience in providing clinical and administrative guidance to software application development for care management, core administration, value-based incentives and value-based reimbursement products for commercial, Medicare and Medicaid programs will be invaluable to MEDai clients.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|